Hypoglycemia or a below normal blood sugar level is a common complication of diabetes. The condition can also arise due to prolonged starvation, certain hormonal disorders such as hypopituitarism and ...

The logo of Lilly is seen on a wall of the Lilly France company unit, part of the Eli Lilly and Co drugmaker group, in Fegersheim near Strasbourg (Reuters) - The U.S. Food and Drug Administration ...

Researchers have shown that a targeted treatment they developed is effective at controlling blood sugar in patients with hyperinsulinism (HI), a genetic disease in which the pancreas produces too much ...

Treatment of factitious hypoglycemia, whether it is insulin- or sulfonylurea-induced, takes place in 2 stages. [3] The first stage involves relieving the neuroglycopenic symptoms by restoring the low ...

Glucagon is underused for treating severe hypoglycemia in both emergency and outpatient settings, new research suggests. Findings from an analysis of data on glucagon administration by emergency ...

UCLA bioengineers and their colleagues have developed a new type of insulin that could help prevent hypoglycemia in people who use the drug to manage diabetes. The treatment is being evaluated for ...

A new study suggests that dextrose gel should be used to treat low blood sugars in newborn babies (neonatal-hypoglycemia) – a common and preventable cause of brain damage. Dextrose gel is an oral ...

CHICAGO--(BUSINESS WIRE)--Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a biopharmaceutical company developing and commercializing unique therapies for patient populations in endocrinology, neurology ...

(NASDAQ:VOGX), a clinical-stage developer of novel therapeutics for the treatment of serious metabolic and gastrointestinal diseases, today announced the initiation of EMERGE (VGX-001-013), its Phase ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Researchers at Children's Hospital of Philadelphia (CHOP) have shown that a targeted treatment they developed is effective at controlling blood sugar in patients with hyperinsulinism (HI), a genetic ...

UCLA bioengineers and their colleagues have developed a new type of insulin that could help prevent hypoglycemia in people who use the drug to manage diabetes. The treatment is being evaluated for ...